Related references
Note: Only part of the references are listed.Caution! Analyze transcripts from conditional knockout alleles
Shao H. Yang et al.
TRANSGENIC RESEARCH (2009)
Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds
Masaru Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer
Anna-Karin M. Sjogren et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A novel protein geranylgeranyltransferase-I inhibitor with high potency, selectivity, and cellular activity
YK Peterson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I
KT Lane et al.
JOURNAL OF LIPID RESEARCH (2006)
Inhibitors of protein: Geranylgeranyl transferases
Farid El Oualid et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Farnesyl transferase inhibitors
AD Basso et al.
JOURNAL OF LIPID RESEARCH (2006)
Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development
N Mijimolle et al.
CANCER CELL (2005)
Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents
SJ DeSolms et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells
NC Crespo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies
SM Sebti et al.
ONCOGENE (2000)
Discovery of (R)-7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity
JT Hunt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules
HR Ashar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
